AAM Comments on Unanimous Supreme Court Decision in Hikma vs. Amarin Affirming Pathway for Generic and Biosimilar Medicines
June 06, 2026
June 06, 2026
WASHINGTON, June 6 -- The Association for Accessible Medicines issued the following news release:
* * *
AAM Comments on Unanimous Supreme Court Decision in Hikma vs. Amarin Affirming Pathway for Generic and Biosimilar Medicines
The Association for Accessible Medicines commented on today's unanimous 9-0 decision in Hikma vs. Amarin in support of the defendant Hikma, a generic medicines manufacturer and AAM member. The case focused on skinny labels, a pa . . .
* * *
AAM Comments on Unanimous Supreme Court Decision in Hikma vs. Amarin Affirming Pathway for Generic and Biosimilar Medicines
The Association for Accessible Medicines commented on today's unanimous 9-0 decision in Hikma vs. Amarin in support of the defendant Hikma, a generic medicines manufacturer and AAM member. The case focused on skinny labels, a pa . . .